Table 5.
Chemotherapy regimens for breast cancer.
| CMF | |
|---|---|
| Cyclophosphomide (CTX) | 100 mg/m2, po, day 1-14 |
| Methotrexate (MTX) | 40 mg/m2, IV gtt, on day 1, 8 |
| 5-Fu | 600 mg/m2, IV gtt, on day 1, 8 |
| Every 28 days/cycle | |
| FAC | |
| 5-Fu | 500 mg/m2, IV gtt, on day 1, 8 |
| Adriamycin (ADM) | 50 mg/m2, IV on day 1 |
| CTX | 500 mg/m2 IV on day 1 |
| Every 21 days/cycle | |
| AC | |
| ADM | 60 mg/m2, IV, on day 1 |
| CTX | 600 mg/m2, IV, on day 1 |
| Every 21 days/cycle | |
| TAC | |
| TXT | 75 mg/m2, IV gtt, on day 1 |
| ADM | 50 mg/m2, IV gtt, on day 1 |
| CTX | 500 mg/m2, IV, on day 1 |
| Every 21 days/cycle | |
| AC->T | |
| ADM | 60 mg/m2, IV, on day 1 |
| CTX | 600 mg/m2, IV, on day 1 |
| Every 21 days/cycle x 4 cycles | |
| Paclitaxel | 175 mg/m2 IV gtt, on day 1 |
| Every 21 days/cycle x 4 cycles | |
| FEC | |
| 5-Fu | 400 mg/m2, IV gtt, on day 1, 8 |
| EPI | 50 mg/m2, IV, on day 1, 8 |
| CTX | 500 mg/m2, IV, on day 1, 8 |
| Every 28 days/cycle |